<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01885390</url>
  </required_header>
  <id_info>
    <org_study_id>RH-03</org_study_id>
    <nct_id>NCT01885390</nct_id>
  </id_info>
  <brief_title>Registry to Evaluate the ROX COUPLER in Patients With Resistant or Uncontrolled Hypertension</brief_title>
  <official_title>ROX CONTROL HTN Registry: To Evaluate the ROX Coupler in Patients With Resistant or Uncontrolled Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ROX Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ROX Medical, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this registry is to evaluate the safety and performance of the ROX COUPLER in
      patients with treatment-resistant or uncontrolled hypertension.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in ambulatory daytime mean systolic blood pressure</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>Change in mean ambulatory daytime systolic blood pressure at six months as compared to Baseline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in ambulatory daytime mean diastolic blood pressure</measure>
    <time_frame>Baseline, 6 months</time_frame>
    <description>Change in mean ambulatory daytime diastolic blood pressure at six months as compared to Baseline.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Hypertension</condition>
  <condition>Blood Pressure, High</condition>
  <condition>Blood Pressure, Resistant</condition>
  <condition>Blood Pressure, Uncontrolled</condition>
  <arm_group>
    <arm_group_label>Experimental: Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ROX Coupler + continuing standard antihypertensive medications</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ROX COUPLER</intervention_name>
    <description>The COUPLER will be used to create an anastomosis in the iliac region (between the iliac artery and vein).</description>
    <arm_group_label>Experimental: Group A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of resistant or uncontrolled hypertension must be made on the basis of
             current findings, medical history, and physical examination.

        Exclusion Criteria:

          -  Any serious medical condition that may adversely affect the patient's safety, limit
             the subject's ability to participate in the registry, comply with follow-up
             requirements, or impact the scientific integrity of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mel Lobo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen Mary University of London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ZNA Cardio Middelheim</name>
      <address>
        <city>Antwerp</city>
        <zip>2020</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Scott, MD</last_name>
      <phone>+32 3 280 32 09</phone>
    </contact>
    <contact_backup>
      <last_name>Martine Oreglia, RN</last_name>
      <phone>+32 3 280 32 09</phone>
      <email>mi.stusec-cardiologie@xna.be</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St. Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <zip>3435CM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benno J. Rensing, MD</last_name>
      <phone>+31 30 609 3267</phone>
      <email>b.rensing@antoniusziekenhuis.nl</email>
    </contact>
    <contact_backup>
      <last_name>Manfred Oostveen, RN</last_name>
      <phone>+31 30 609 3267</phone>
      <email>ch.oostveen@antoniusziekenhuis.nl</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>East Sussex Healthcare NHS Trust</name>
      <address>
        <city>Eastbourne</city>
        <zip>BN21 2UD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steve Furniss, MD</last_name>
      <email>steve.furniss@esht.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Sarah Bridgland, BS</last_name>
      <email>sarah.bridgland@esht.uk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Queen Mary University of London</name>
      <address>
        <city>London</city>
        <zip>EC1M 6BQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mel Lobo, MD</last_name>
      <phone>020 7882 3416</phone>
      <email>m.d.lobo@qmul.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Anne Zak, RN</last_name>
      <phone>020 7882 5660</phone>
      <email>a.zak@qmul.ac.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Mel Lobo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Netherlands</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2013</study_first_submitted>
  <study_first_submitted_qc>June 20, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2013</study_first_posted>
  <last_update_submitted>March 29, 2018</last_update_submitted>
  <last_update_submitted_qc>March 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>High blood pressure</keyword>
  <keyword>Resistant blood pressure</keyword>
  <keyword>Uncontrolled blood pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

